evans blue has been researched along with alpha-cyano-4-hydroxycinnamate in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Karolczak, K; Labieniec-Watala, M; Rozalska, S; Watala, C; Wieczorek, M | 1 |
1 other study(ies) available for evans blue and alpha-cyano-4-hydroxycinnamate
| Article | Year |
|---|---|
Poly(amido)amine dendrimers generation 4.0 (PAMAM G4) reduce blood hyperglycaemia and restore impaired blood-brain barrier permeability in streptozotocin diabetes in rats.
Topics: Animals; Blood Glucose; Brain; Coumaric Acids; Dendrimers; Dextrans; Diabetes Mellitus, Experimental; Evans Blue; Fluorescein; Fluorescein-5-isothiocyanate; Fluorescent Dyes; Hyperglycemia; Monocarboxylic Acid Transporters; Nylons; Permeability; Rats; Rats, Sprague-Dawley; Symporters | 2012 |